3rkd:H (VAL2) to (VAL103) HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY | HEPATITIS E VIRUS CAPSID PROTEIN, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3rkd:D (VAL2) to (VAL103) HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY | HEPATITIS E VIRUS CAPSID PROTEIN, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1nc4:A (ALA2) to (SER95) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD- DOTA | ANTIBODY-DOTA COMPLEX, RARE EARTH, DOTA, METAL CHELATE, GADOLINIUM, GAMMA TURN, N-LINKED GLYCOSYLATION, IMMUNE SYSTEM
1ncb:H (ILE2) to (ALA93) CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE | HYDROLASE(O-GLYCOSYL)
1ncd:L (VAL3) to (TYR92) REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX | HYDROLASE(O-GLYCOSYL)
1ahw:B (GLN3) to (SER101) A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9) | BLOOD COAGULATION, TISSUE FACTOR, FAB, COMPLEX, ANTIBODY, COMPLEX (IMMUNOGLOBULIN/TISSUE FACTOR)
3rvu:D (VAL2) to (TYR102) STRUCTURE OF 4C1 FAB IN C2221 SPACE GROUP | IGG, ANTIBODY, DER F 1, DER P 1, IMMUNE SYSTEM
3rvx:D (GLU1) to (TYR102) CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1 | DER P 1, ALLERGEN-ANTIBODY COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX
2oqj:B (GLN3) to (CYS92) CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
2oqj:E (GLN3) to (CYS92) CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
2oqj:H (GLN3) to (CYS92) CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
2or9:H (VAL2) to (TYR100) THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT/EPITOPE PEPTIDE COMPLEX REVEALS A NOVEL BINDING MODE DOMINATED BY THE HEAVY CHAIN HYPERVARIABLE LOOPS | ANTIGEN-ANTIBODY COMPLEX, ANTIGEN RECOGNITION, MYC-TAG, LONG CDR H3, IMMUNE SYSTEM
2or9:I (VAL2) to (GLU97) THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT/EPITOPE PEPTIDE COMPLEX REVEALS A NOVEL BINDING MODE DOMINATED BY THE HEAVY CHAIN HYPERVARIABLE LOOPS | ANTIGEN-ANTIBODY COMPLEX, ANTIGEN RECOGNITION, MYC-TAG, LONG CDR H3, IMMUNE SYSTEM
3ejy:E (VAL2) to (TYR103) STRUCTURE OF E203H MUTANT OF E.COLI CL-/H+ ANTIPORTER, CLC-EC1 | MEMBRANE PROTEIN, CL-/H+ EXCHANGER, ANTIPORT, CELL INNER MEMBRANE, CELL MEMBRANE, CHLORIDE, ION TRANSPORT, STRESS RESPONSE, TRANSMEMBRANE, TRANSPORT, IMMUNE SYSTEM-PROTON TRANSPORT COMPLEX
3ejz:C (VAL2) to (TYR103) STRUCTURE OF E203V MUTANT E.COLI CL-/H+ EXCHANGER, CLC-EC1 | MEMBRANE PROTEIN, CL-/H+ EXCHANGER, ANTIPORT, CELL INNER MEMBRANE, CELL MEMBRANE, CHLORIDE, ION TRANSPORT, STRESS RESPONSE, TRANSMEMBRANE, TRANSPORT, IMMUNE SYSTEM-PROTON TRANSPORT COMPLEX
3ejz:E (VAL2) to (TYR103) STRUCTURE OF E203V MUTANT E.COLI CL-/H+ EXCHANGER, CLC-EC1 | MEMBRANE PROTEIN, CL-/H+ EXCHANGER, ANTIPORT, CELL INNER MEMBRANE, CELL MEMBRANE, CHLORIDE, ION TRANSPORT, STRESS RESPONSE, TRANSMEMBRANE, TRANSPORT, IMMUNE SYSTEM-PROTON TRANSPORT COMPLEX
3eo9:H (VAL2) to (PHE102) CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB | EFALIZUMAB, FAB, ANTIBODY, IMMUNE SYSTEM
4wuk:H (VAL2) to (ARG94) CRYSTAL STRUCTURE OF APO CH65 FAB | IMMUNOGLOBULIN
2p1y:G (ALA3) to (SER94) 1.B2.D9, A BISPECIFIC ALPHA/BETA TCR | TCR, AUTOIMMUNITY, IMMUNOGLOBULIN FOLD, DIABODY, IMMUNE SYSTEM
4hcr:M (VAL2) to (SER101) CRYSTAL STRUCTURE OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB PF-547659 | IMMUNOGLOBULIN SUPERFAMILY, ROLLING AND FIRM ADHESION, INTEGRIN ALPHA4BETA7, IMMUNE SYSTEM
4hgw:B (VAL2) to (ALA93) CRYSTAL STRUCTURE OF S25-2 IN COMPLEX WITH A 5,6-DEHYDRO-KDO DISACCHARIDE | ANTIBODY, LPS, IMMUNE SYSTEM
4hk0:D (SER2) to (SER92) UCA FAB (UNBOUND) FROM CH65-CH67 LINEAGE | FAB FRAGMENT, IMMUNE SYSTEM
4hkb:J (VAL2) to (ARG98) CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE | FAB FRAGMENT, IMMUNE SYSTEM
4hkb:A (VAL2) to (ARG98) CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE | FAB FRAGMENT, IMMUNE SYSTEM
4hkb:G (VAL2) to (ARG98) CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE | FAB FRAGMENT, IMMUNE SYSTEM
4hkx:A (GLN3) to (ARG98) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH CH67 FAB | FAB FRAGMENT, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2bmk:H (VAL2) to (ARG94) FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE | CATALYTIC ANTIBODY, TRANSAMINATION, PYRIDOXAL-PHOSPHATE, HAPTEN, PHOSPHOPYRIDOXYL-L-LYSINE, IMMUNE SYSTEM
4x6b:C (GLU2) to (THR92) BK6 TCR APO STRUCTURE | T CELL RECEPTOR, CD1A, AUTOIMMUNITY, LIPID ANTIGEN, IMMUNE SYSTEM
4x6c:E (GLU2) to (THR92) CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR | CD1A, TCR, IMMUNE COMPLEX, LIPID ANTIGEN, IMMUNE SYSTEM
4x6c:G (GLU2) to (THR92) CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR | CD1A, TCR, IMMUNE COMPLEX, LIPID ANTIGEN, IMMUNE SYSTEM
4x7f:C (GLN3) to (ASN96) CRYSTAL STRUCTURE OF NOROVIRUS GII.10 P DOMAIN IN COMPLEX WITH NANO-25 | NANOBODY, VHH DOMAIN, NOROVIRUS, PROTRUDING DOMAIN, VIRAL PROTEIN
4hpo:H (VAL2) to (ARG98) CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58 IN COMPLEX WITH V2 PEPTIDE | IMMUNOGLOBULIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
1oak:H (GLN217) to (ASP315) CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB | VON WILLEBRAND FACTOR, GLYCOPROTEIN IBA (A:ALPHA) BINDING, COMPLEX (WILLEBRAND/IMMUNOGLOBULIN), BLOOD COAGULATION
4xbe:H (GLN1) to (THR98) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SPHINGOMYELIN (02:0 SM (D18:1/2:0)). | HIV-1 GP41 MPER, 4E10 FAB, MEMBRANE LIPID, IMMUNE SYSTEM
4xbg:E (GLN1) to (THR98) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM
4xbg:G (VAL2) to (THR98) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM
4xbg:J (GLN1) to (THR98) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM
4xbp:A (GLN1) to (THR98) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE) | HUMAN 4E10 FAB ANTI HIV-1 GP41, MEMBRANE LIPIDS, PHOSPHATIDYLETHANOLAMINE, IMMUNE SYSTEM
3sbw:A (SER34) to (HIS129) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EXTRACELLULAR DOMAINS OF MOUSE PD-1 MUTANT AND HUMAN PD-L1 | PD-1; PD-L1; B7-H1; PROGRAMMED DEATH-1 LIGAND 1, COMPLEX, COSTIMULATORY, IMMUNE SYSTEM
2bx5:H (ILE2) to (GLN89) IS FR1 THE ANTIBODY'S ACHILLIES HEEL | IMMUNE SYSTEM, AMYLOID, LCDD, ANTIBODY, AGGREGATION, FR1
4xcc:H (GLN3) to (THR98) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); I422 SPACE GROUP | 4E10 FAB ANTI HIV-1 GP41, LIPID MEMBRANE, IMMUNE SYSTEM, PHOSPHATIDYLCHOLINE
4xce:H (GLN1) to (ARG94) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); C2 SPACE GROUP | 4E10 FAB ANTI HIV-1 GP41, PHOSPHATIDYLCHOLINE, MEMBRANE LIPID, IMMUNE SYSTEM
4xce:A (VAL2) to (ARG94) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); C2 SPACE GROUP | 4E10 FAB ANTI HIV-1 GP41, PHOSPHATIDYLCHOLINE, MEMBRANE LIPID, IMMUNE SYSTEM
4xcn:J (VAL2) to (THR98) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPIDS, PHOSPHATIDIC ACID, IMMUNE SYSTEM
1om3:K (GLN3) to (ARG99) FAB 2G12 UNLIGANDED | FAB 2G12, THREE-DIMENSIONAL DOMAIN SWAP, IMMUNE SYSTEM
1op3:M (GLN3) to (GLY96) CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN1->2MAN | DOMAIN-SWAPPED FAB 2G12; ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
3sm5:H (VAL2) to (ARG98) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY | INFLUENZA HEMAGGLUTININ, IMMUNE SYSTEM
3sm5:I (VAL2) to (ARG98) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY | INFLUENZA HEMAGGLUTININ, IMMUNE SYSTEM
3sm5:J (VAL2) to (ARG98) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY | INFLUENZA HEMAGGLUTININ, IMMUNE SYSTEM
1opg:H (VAL2) to (PRO100) OPG2 FAB FRAGMENT | CELL ADHESION MOLECULE, IMMUNOGLOBULIN
3so3:C (GLN3) to (GLY97) STRUCTURES OF FAB-PROTEASE COMPLEXES REVEAL A HIGHLY SPECIFIC NON- CANONICAL MECHANISM OF INHIBITION. | ANTIBODY-PROTEIN, PROTEIN-PROTEIN, PROTEASE INHIBITOR, DISEASE MUTATION, GLYCOPROTEIN, HYDROLASE, MEMBRANE, SERINE PROTEASE, SIGNAL-ANCHOR, TRANSMEMBRANE
1ots:C (VAL2) to (TYR103) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL AND FAB COMPLEX | CLC CHLORIDE CHANNEL, FAB COMPLEX, MEMBRANE PROTEIN
1ots:E (VAL2) to (TYR103) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL AND FAB COMPLEX | CLC CHLORIDE CHANNEL, FAB COMPLEX, MEMBRANE PROTEIN
1otu:C (LEU4) to (TYR103) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148Q MUTANT AND FAB COMPLEX | ION CHANNEL, CLC CHLORIDE CHANNEL, FAB COMPLEX, MEMBRANE PROTEIN
3g5x:B (VAL2) to (GLY98) ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR | ANTIBODY, IMMUNE SYSTEM
4imk:A (GLN3) to (PRO100) UNCROSSED FAB BINDING TO HUMAN ANGIOPOIETIN 2 | ANTIGEN-BINDING FRAGMENT (FAB), HUMAN ANGIOPOIETIN 2, IMMUNE SYSTEM
4imk:B (GLN3) to (PRO100) UNCROSSED FAB BINDING TO HUMAN ANGIOPOIETIN 2 | ANTIGEN-BINDING FRAGMENT (FAB), HUMAN ANGIOPOIETIN 2, IMMUNE SYSTEM
1dl7:H (GLN1) to (ARG97) THE STRUCTURAL BASIS OF REPERTOIRE SHIFT IN AN IMMUNE RESPONSE TO PHOSPHOCHOLINE | SINGLE CHAIN FV, REPERTOIRE SHIFT, IMMUNE SYSTEM
4xt1:C (GLN3) to (THR100) STRUCTURE OF A NANOBODY-BOUND VIRAL GPCR BOUND TO HUMAN CHEMOKINE CX3CL1 | GPCR, CHEMOKINE, MEMBRANE PROTEIN, COMPLEX, VIRAL PROTEIN-SIGNALLING PROTEIN COMPLEX
4xtr:E (GLN6) to (ARG103) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF PEP12 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
4xvu:E (GLU4) to (ARG103) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
3ghb:H (GLN3) to (VAL100) CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020 | HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, ENVELOPE PROTEIN, IMMUNE SYSTEM
3ghb:I (GLN3) to (VAL100) CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020 | HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, ENVELOPE PROTEIN, IMMUNE SYSTEM
2qsc:H (GLN3) to (TYR98) CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3-FAB F425-B4E8 IN COMPLEX WITH A V3-PEPTIDE | FAB-PEPTIDE COMPLEX, HIV-1, GP120, V3 LOOP, IMMUNOGLOBULIN FOLD, AIDS, APOPTOSIS, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRAL IMMUNOEVASION, VIRION, IMMUNE SYSTEM
3tcl:H (GLN3) to (ALA93) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY CH04 | IG, IMMUNOGLOBULIN, IMMUNE SYSTEM
3tcl:A (GLN3) to (THR96) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY CH04 | IG, IMMUNOGLOBULIN, IMMUNE SYSTEM
1q1j:I (GLN3) to (VAL100) CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE | FAB-PEPTIDE COMPLEX, HIV-1, GP120, V3 LOOP, IMMUNE SYSTEM
2dqt:H (VAL2) to (SER96) HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG | CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM
2dqu:H (LYS3) to (ARG94) CRYSTAL FORM II: HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG | CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM
2r9h:C (VAL2) to (CYS96) CRYSTAL STRUCTURE OF Q207C MUTANT OF CLC-EC1 IN COMPLEX WITH FAB | CLC, ANTIPORTER, TRANSPORTER, EXCHANGER, DISULFIDE, CROSSLINK, MEMBRANE PROTEIN, CHLORIDE, INNER MEMBRANE, ION TRANSPORT, STRESS RESPONSE, TRANSMEMBRANE
3tpu:H (VAL4) to (ASP95) 42F3 P5E8/H2-LD COMPLEX | IG MHC, ANTIGEN RECOGNITION, TCR-PMHC, CHIMERA PROTEIN, MEMBRANE RECEPTOR, IMMUNE SYSTEM
4ydk:H (VAL2) to (PHE97) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC16.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120 | ANTIBODY, HIV-1, IMMUNE SYSTEM
4ydv:H (GLN3) to (GLY97) STRUCTURE OF THE ANTIBODY 7B2 THAT CAPTURES HIV-1 VIRIONS | IGG, HIV, ANTIBODY, HIV GP41 ENVELOPE PROTEIN, IMMUNE SYSTEM
4ydv:B (GLN3) to (GLY97) STRUCTURE OF THE ANTIBODY 7B2 THAT CAPTURES HIV-1 VIRIONS | IGG, HIV, ANTIBODY, HIV GP41 ENVELOPE PROTEIN, IMMUNE SYSTEM
1eo8:L (ILE2) to (SER92) INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY | COMPLEX (HEMAGGLUTININ-IMMMUNOGLOBULIN), HEMAGGLUTININ, IMMUNOGLOBULIN, VIRAL PROTEIN, IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
3h0t:B (GLN1) to (ALA100) HEPCIDIN-FAB COMPLEX | PEPTIDE-FAB COMPLEX, ANTIBIOTIC, ANTIMICROBIAL, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISEASE MUTATION, DISULFIDE BOND, FUNGICIDE, HORMONE, SECRETED, IMMUNE SYSTEM/ANTIMICROBIAL PROTEIN COMPLEX
1etz:B (VAL2) to (TYR104) THE THREE-DIMENSIONAL STRUCTURE OF AN ANTI-SWEETENER FAB, NC10.14, SHOWS THE EXTENT OF STRUCTURAL DIVERSITY IN ANTIGEN RECOGNITION BY IMMUNOGLOBULINS | ANTI-SWEETENER FAB, ANTIGEN-ANTIBODY, COMPLEX, CRYSTAL STRUCTURE, RECEPTOR MIMICRY, ANTIGEN RECOGNITION, IMMUNE SYSTEM
1f58:H (ASP1) to (ALA97) IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 24-RESIDUE PEPTIDE (RESIDUES 308-333 OF HIV-1 GP120 (MN ISOLATE) WITH ALA TO AIB SUBSTITUTION AT POSITION 323 | IMMUNOGLOBULIN, FAB, HIV-1, GP120, V3, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
4jzn:B (TYR2) to (VAL89) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-1 | FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4jzn:D (TYR2) to (VAL89) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-1 | FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4jzn:P (TYR2) to (VAL89) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-1 | FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4yr6:A (VAL2) to (THR103) FAB FRAGMENT OF 5G6 IN COMPLEX WITH EPITOPE PEPTIDE | GPIBA SHEDDING INHIBITOR, 5G6, KL10, IMMUNE SYSTEM
4yr6:D (VAL2) to (THR103) FAB FRAGMENT OF 5G6 IN COMPLEX WITH EPITOPE PEPTIDE | GPIBA SHEDDING INHIBITOR, 5G6, KL10, IMMUNE SYSTEM
2esv:D (LYS4) to (SER94) STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX | T CELL RECEPTOR, TCR, HLA-E, CMV, PMHC/TCR COMPLEX, IMMUNE SYSTEM
4k3d:I (GLN3) to (LYS104) CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV1H12 WITH ULTRALONG CDR H3 | IMMUNOGLOBULIN, CYSTINE KNOT, IMMUNE RECOGNITION, IMMUNE SYSTEM
1fns:H (VAL216) to (PRO313) CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN I546V MUTANT IN COMPLEX WITH THE FUNCTION BLOCKING FAB NMC4 | VON WILLEBRAND FACTOR, GLYCOPROTEIN IBA (A:ALPHA) BINDING, COMPLEX (WILLEBRAND-IMMUNOGLOBULIN), BLOOD COAGULATION TYPE 2B VON WILLEBRAND DISEASE, IMMUNE SYSTEM
2exw:C (VAL2) to (TYR103) CRYSTAL STRUCTURE OF A ECCLC-FAB COMPLEX IN THE ABSENCE OF BOUND IONS | CLC FAMILY OF CL- CHANNELS AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN/FAB COMPLEX
2exy:C (LEU4) to (TYR103) CRYSTAL STRUCTURE OF THE E148Q MUTANT OF ECCLC, FAB COMPLEXED IN ABSENCE OF BOUND IONS | CLC FAMILY OF CHANNELS AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN/FAB COMPLEX
2exy:E (VAL2) to (TYR103) CRYSTAL STRUCTURE OF THE E148Q MUTANT OF ECCLC, FAB COMPLEXED IN ABSENCE OF BOUND IONS | CLC FAMILY OF CHANNELS AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN/FAB COMPLEX
3ujj:H (VAL2) to (ILE94) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 4025 IN COMPLEX WITH CON A PEPTIDE | IG DOMAINS, ANTIBODY FAB, ANTIGEN BINDING, THE THIRD VARIABLE REGION OF HIV-1 GP120, IMMUNE SYSTEM
1ri8:A (VAL2) to (ALA96) CRYSTAL STRUCTURE OF THE CAMELID SINGLE DOMAIN ANTIBODY 1D2L19 IN COMPLEX WITH HEN EGG WHITE LYSOZYME | BETA SANDWICH, IMMUNOGLOBULIN FOLD, VHH-LYSOZYME COMPLEX, ALPHA-BETA ORTHOGONAL BUNDLE, IMMUNE SYSTEM-HYDROLASE COMPLEX
4kaq:H (VAL2) to (TYR101) STRUCTURE OF RITUXIMAB FAB | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
2fec:I (VAL2) to (TYR103) STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI | CLC-EC1; CLCA_ECOLI; CHLORIDE/PROTON EXCHANGE TRANSPORTER, PROTON TRANSPORT,MEMBRANE PROTEIN
2fee:I (VAL2) to (TYR103) STRUCTURE OF THE CL-/H+ EXCHANGER CLC-EC1 FROM E.COLI IN NABR | CLC-EC1; CLCA_ECOLI; CHLORIDE/PROTON EXCHANGE TRANSPORTER, PROTON TRANSPORT,MEMBRANE PROTEIN
2fed:E (VAL2) to (TYR103) STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI | CLC-EC1; CLCA_ECOLI; CHLORIDE/PROTON EXCHANGE TRANSPORTER, PROTON TRANSPORT,MEMBRANE PROTEIN
4kjq:C (VAL2) to (TYR103) STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE | MEMBRANE TRANSPORTER, FLUORIDE, TRANPORT PROTEIN, MEMBRANE PROTEIN
4kjw:C (VAL2) to (TYR103) STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN, MEMBRANE PROTEIN
4kjw:E (VAL2) to (TYR103) STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN, MEMBRANE PROTEIN
2vis:B (GLN3) to (ARG97) INFLUENZA VIRUS HEMAGGLUTININ, (ESCAPE) MUTANT WITH THR 131 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY | COMPLEX (HEMAGGLUTININ-IMMUNOGLOBULIN), GLYCOPROTEIN, COMPLEX (HEMAGGLUTININ-IMMUNOGLOBULIN) COMPLEX
2vit:B (VAL2) to (ARG97) INFLUENZA VIRUS HEMAGGLUTININ, MUTANT WITH THR 155 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY | COMPLEX (HEMAGGLUTININ/IMMMUNOGLOBULIN), GLYCOPROTEIN
4kk5:C (VAL2) to (TYR103) STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE | MEMBRANE TRANSPORTER, FLUORIDE, BROMIDE, TRANSPORT PROTEIN
4kk5:E (VAL2) to (TYR103) STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE | MEMBRANE TRANSPORTER, FLUORIDE, BROMIDE, TRANSPORT PROTEIN
4kk6:C (VAL2) to (TYR103) STRUCTURE OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN
4kk6:E (VAL2) to (TYR103) STRUCTURE OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN
4kk9:C (VAL2) to (TYR103) STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 2MM BROMIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN
4kk9:E (VAL2) to (TYR103) STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 2MM BROMIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN
4kka:C (VAL2) to (TYR103) STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN
4kka:E (VAL2) to (TYR103) STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN
4kkc:C (VAL2) to (TYR103) STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN
4kkc:E (VAL2) to (TYR103) STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN
4kkl:C (VAL2) to (TYR103) STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTA NC CONSTRUCT IN 100MM FLUORIDE | MEMBRANE TRANSPORTER, TRANPORT PROTEIN, MEMBRANE PROTEIN
4kkl:E (VAL2) to (TYR103) STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTA NC CONSTRUCT IN 100MM FLUORIDE | MEMBRANE TRANSPORTER, TRANPORT PROTEIN, MEMBRANE PROTEIN
4z7u:E (ALA2) to (ARG109) S13 COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4kml:B (ALA1) to (ARG98) PROBING THE N-TERMINAL BETA-SHEET CONVERSION IN THE CRYSTAL STRUCTURE OF THE FULL-LENGTH HUMAN PRION PROTEIN BOUND TO A NANOBODY | PRION-LIKE FOLD, ANTIBODY, NANOBODY, MEMBRANE PROTEIN-PROTEIN BINDING COMPLEX
4z9k:B (GLN3) to (ALA93) RICIN A CHAIN BOUND TO CAMELID NANOBODY (VHH2)(F5) | RICIN TOXIN, NANOBODIES, HYDROLASE-IMMUNE SYSTEM COMPLEX
1sbb:A (ALA3) to (SER94) T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SUPERANTIGEN SEB | T CELL RECEPTOR, SUPERANTIGEN, COMPLEX, IMMUNE SYSTEM
3v4p:H (VAL2) to (ASP102) CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 | CELL ADHESION, MADCAM-1, MEMBRANE
3v4p:M (VAL2) to (ASP102) CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 | CELL ADHESION, MADCAM-1, MEMBRANE
2fx8:I (GLN1) to (ARG94) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41 | IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM
2fx8:J (GLN1) to (THR97) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41 | IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM
3hzk:B (VAL2) to (ARG94) CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO | ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM
3hzm:B (VAL2) to (ARG94) CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO | ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM
3hzv:B (VAL2) to (ARG94) CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.8) KDO(2.4)KDO | ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM
4krm:F (GLN1) to (ALA100) NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR, PH 3.5 | CELL SURFACE RECEPTOR, GLYCOPROTEIN, NANOBODY, VHH DOMAIN, CAMELID VH DOMAIN, ANTIBODY, ANTIGEN, ANTIBODY COMPLEX, TRANSFERASE-IMMUNE SYSTEM COMPLEX
4kv5:E (VAL2) to (SER98) SCFV GC1009 IN COMPLEX WITH TGF-BETA1. | CYSTEINE KNOT, FAB, TGF-BETA RECEPTOR MIMETIC, TGF-BETA, TGF-BETA RECEPTOR, IMMUNE SYSTEM
4kvc:L (VAL3) to (TYR92) 2H2 FAB FRAGMENT OF IMMATURE DENGUE VIRUS | FAB FRAGMENT, IMMATURE DENGUE, PR PEPTIDE, IMMUNE SYSTEM
2gfb:D (VAL2) to (ARG94) CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY | IMMUNOGLOBULIN
2gfb:H (VAL2) to (ARG94) CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY | IMMUNOGLOBULIN
3vg9:C (VAL2) to (TYR103) CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 2.7 A RESOLUTION | 7 TRANSMEMBRANE RECEPTOR, SIGNAL TRANSDUCTION, SIGNALING PROTEIN
4zs7:H (LEU4) to (ASP102) STRUCTURAL MIMICRY OF RECEPTOR INTERACTION BY ANTAGONISTIC IL-6 ANTIBODIES | INTERLEUKINE 6 COMPLEX, FAB FRAGMENT, DROMEDERY, IMMUNE SYSTEM
4lgp:B (GLN1) to (VAL97) RICIN A CHAIN BOUND TO CAMELID NANOBODY (VHH1) | RIBOSOME INHIBITING PROTEIN 2, CAMELID ANTIBODY (VHH), HYDROLASE- IMMUNE SYSTEM COMPLEX
1hh9:B (ASP2) to (ARG98) ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE | IMMUNE SYSTEM/PEPTIDE, COMPLEX (ANTIBODY/PEPTIDE), POLYSPECIFICITY, CROSSREACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1
2h2p:C (VAL2) to (TYR103) CRYSTAL STRUCTURE OF CLC-EC1 IN COMPLEX WITH FAB FRAGMENT IN SECN- | CLC; TRANSPORTER; CHLORIDE; ANTIPORT, ION TRANSPORT
2h32:A (VAL3) to (SER102) CRYSTAL STRUCTURE OF THE PRE-B CELL RECEPTOR | BETA SHEETS, V AND C-TYPE IG FOLDS, IMMUNE SYSTEM
2h9g:B (GLU1) to (ARG94) CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5) | PHAGE DISPLAY, PROTEIN ENGINEERING, COMBINATORIAL MUTAGENESIS, ANTIBODY LIBRARY, DEATH RECEPTOR-5, AGONISTS, IMMUNE SYSTEM- APOPTOSIS COMPLEX
4llv:F (ILE2) to (GLY92) THE STRUCTURE OF THE UNBOUND FORM OF ANTI-HIV ANTIBODY 4E10 FV | 4E10, FV, HIV, IMMUNOGLOBULIN, ANTIBODY, IMMUNE SYSTEM
5a16:A (VAL2) to (TYR102) CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1 | IMMUNE SYSTEM, FAB FRAGMENT, ANION EXCHANGER
5a16:C (VAL2) to (GLY103) CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1 | IMMUNE SYSTEM, FAB FRAGMENT, ANION EXCHANGER
5a16:E (VAL2) to (TYR102) CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1 | IMMUNE SYSTEM, FAB FRAGMENT, ANION EXCHANGER
5a16:G (VAL2) to (TYR102) CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1 | IMMUNE SYSTEM, FAB FRAGMENT, ANION EXCHANGER
2hlf:C (VAL2) to (TYR103) STRUCTURE OF THE ESCHERICHIS COLI CLC CHLORIDE CHANNEL Y445E MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNELS AND TRANSPOTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX, PROTON TRANSPORT,MEMBRANE PROTEIN
2hlf:E (VAL2) to (TYR103) STRUCTURE OF THE ESCHERICHIS COLI CLC CHLORIDE CHANNEL Y445E MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNELS AND TRANSPOTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX, PROTON TRANSPORT,MEMBRANE PROTEIN
4lou:C (VAL2) to (TYR103) STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE | CL-/H+ ANTIPORTER, MEMBRANE PROTEIN, TRANPORT PROTEIN
1hzh:H (VAL2) to (ARG94) CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | IMMUNOGLOBULIN, ANTIBODY, B12, IMMUNE SYSTEM
1hzh:K (VAL2) to (ARG94) CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | IMMUNOGLOBULIN, ANTIBODY, B12, IMMUNE SYSTEM
3vxt:D (VAL4) to (GLY95) T36-5 TCR SPECIFIC FOR HLA-A24-NEF134-10 | HIV-1, NEF, IMMUNE SYSTEM, T CELL RECEPTOR, IMMUNOGLOBURIN DOMAIN, TCR, IMMUNE RESPONSE
2hrp:H (VAL2) to (ARG94) ANTIGEN-ANTIBODY COMPLEX | FAB FRAGMENT, CROSS-REACTIVITY, HIV1 PROTEASE, ENZYME INHIBITION, COMPLEX (IMMUNOGLOBULIN/PEPTIDE)
2hrp:N (VAL2) to (TYR100) ANTIGEN-ANTIBODY COMPLEX | FAB FRAGMENT, CROSS-REACTIVITY, HIV1 PROTEASE, ENZYME INHIBITION, COMPLEX (IMMUNOGLOBULIN/PEPTIDE)
3w0w:E (VAL4) to (ALA96) THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE IN SPACE GROUP P212121 | HIV-1, NEF, HLA-A24, T CELL RECEPTOR, MHC CLASS I, TCR, MHC, IMMUNOGLOBURIN DOMAIN, IMMUNE SYSTEM, IMMUNE RESPONSE
2ht2:C (VAL2) to (TYR103) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445H MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
2ht2:E (VAL2) to (TYR103) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445H MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
2ht3:C (VAL2) to (TYR103) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445L MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
2ht4:C (VAL2) to (TYR103) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445W MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
2ht4:E (VAL2) to (TYR103) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445W MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
2htk:C (VAL2) to (TYR103) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445A MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
2htk:E (VAL2) to (TYR103) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445A MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
2htl:C (VAL2) to (TYR103) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445F MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
2htl:E (VAL2) to (TYR103) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445F MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
3iyw:H (VAL2) to (ARG98) WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU) | VIRUS-ANTIBODY COMPLEX, NEUTRALIZING FAB FRAGMENT, FLAVIVIRUS, WEST NILE VIRUS, ENVELOPE PROTEIN, ICOSAHEDRAL VIRUS, VIRUS
3iyw:K (VAL2) to (ARG98) WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU) | VIRUS-ANTIBODY COMPLEX, NEUTRALIZING FAB FRAGMENT, FLAVIVIRUS, WEST NILE VIRUS, ENVELOPE PROTEIN, ICOSAHEDRAL VIRUS, VIRUS
4m1d:H (GLN3) to (VAL100) CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN | HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, ENVELOPE, IMMUNE SYSTEM
4may:C (GLU2) to (SER94) CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX | IMMUNE COMPLEX, AUTOIMMUNITY, MULTIPLE SCLEROSIS, ANTIGEN PRESENTATION, IMMUNE SYSTEM
2x1p:B (GLN3) to (HIS101) GELSOLIN NANOBODY | CONTRACTILE PROTEIN
2x1p:C (GLN3) to (HIS101) GELSOLIN NANOBODY | CONTRACTILE PROTEIN
2x1q:A (GLN3) to (SER100) GELSOLIN NANOBODY | CONTRACTILE PROTEIN
2x1q:B (GLN3) to (SER100) GELSOLIN NANOBODY | CONTRACTILE PROTEIN
1v7n:O (VAL2) to (SER91) HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB | THROMBOPOIETIN, FAB FRAGMENT, COMPLEX (CYTOKINE/ANTIBODY), IMMUNE SYSTEM/CYTOKINE COMPLEX
1jck:A (ALA3) to (SER94) T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SEC3 SUPERANTIGEN | T-CELL, RECEPTOR, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, ENTEROTOXIN, TOXIN, SUPERANTIGEN, COMPLEX (TOXIN/RECEPTOR)
1jck:C (ALA3) to (SER94) T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SEC3 SUPERANTIGEN | T-CELL, RECEPTOR, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, ENTEROTOXIN, TOXIN, SUPERANTIGEN, COMPLEX (TOXIN/RECEPTOR)
1vge:H (LEU4) to (ARG99) TR1.9 FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY | TR1.9, ANTI-THYROID PEROXIDASE, AUTOANTIBODY, IMMUNOGLOBULIN
4mqx:C (VAL2) to (TYR103) CLC-EC1 FAB COMPLEX CYSLESS A399C-A432C MUTANT | ALPHA HELICAL TRANSMEMBRANE PROTEIN, CL/H ANTIPORTER, METAL TRANSPORT, MEMBRANE PROTEIN
4mqx:E (VAL2) to (TYR103) CLC-EC1 FAB COMPLEX CYSLESS A399C-A432C MUTANT | ALPHA HELICAL TRANSMEMBRANE PROTEIN, CL/H ANTIPORTER, METAL TRANSPORT, MEMBRANE PROTEIN
4mwf:H (GLN2) to (THR97) STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C | IMMUNOGLOBULIN FOLD, HCV E2, IMMUNE SYSTEM
3wxv:L (GLN3) to (TRP92) CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 1 | PAQR FAMILY, ADIPONECTIN, OSMOTIN, APPL1, APPL2, MEMBRANE, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
4n0y:H (GLN3) to (ARG94) STRUCTURE OF THE HEPATITIS C ENVELOPE GLYCOPROTEIN E1 ANTIGENIC REGION 314-324 BOUND TO THE CROSS-NEUTRALIZING ANTIBODY IGH526 | IMMUNOGLOBULIN FOLD, AMIDATED C-TERMINUS, IMMUNE SYSTEM
2xtj:D (GLN3) to (TYR107) THE CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH 1D05 FAB | HYDROLASE-ANTIBODY COMPLEX, SERINE PROTEASE, LDL-C, LDLR, EGF-A, HYPERCHOLESTEROLEMIA
4n9o:B (ALA1) to (ALA97) PROBING THE N-TERMINAL BETA-SHEET CONVERSION IN THE CRYSTAL STRUCTURE OF THE HUMAN PRION PROTEIN BOUND TO A NANOBODY | PRION-LIKE FOLD, ANTIBODY, NANOBODY, MEMBRANE PROTEIN-PROTEIN BINDING COMPLEX
3zhd:A (VAL2) to (CYS96) THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 8-4 SCAFFOLD. | IMMUNE SYSTEM, SINGLE DOMAIN ANTIBODY
3zhd:B (VAL2) to (CYS96) THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 8-4 SCAFFOLD. | IMMUNE SYSTEM, SINGLE DOMAIN ANTIBODY
3zhk:B (VAL2) to (ALA100) THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 2X1 SCAFFOLD | IMMUNE SYSTEM, SINGLE DOMAIN ANTIBODY
1wc7:H (VAL2) to (ARG94) FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE | ANTIBODY, CATALYTIC ANTIBODY, TRANSAMINATION, PYRIDOXAL-PHOSPHATE, PHOSPHOPYRIDOXYL-L-ALANINE
1kb5:H (VAL2) to (ARG96) MURINE T-CELL RECEPTOR VARIABLE DOMAIN/FAB COMPLEX | T-CELL RECEPTOR, STRAND SWITCH, FAB, ANTICLONOTYPIC, (IMMUNOGLOBULIN/RECEPTOR), COMPLEX (IMMUNOGLOBULIN/RECEPTOR) COMPLEX
4nhh:I (GLN3) to (CYS94) STRUCTURE OF 2G12 IGG DIMER | IG, ANTIBODY, IMMUNE SYSTEM
4nhu:B (ALA3) to (GLY96) THE M33 TCR P3M33L/H-2 LD COMPLEX | IG, TCR, MHC, ANTIGEN, IMMUNE SYSTEM
5c3l:D (GLN1) to (ALA97) STRUCTURE OF THE METAZOAN NUP62.NUP58.NUP54 NUCLEOPORIN COMPLEX. | NUCLEOPORIN, HETEROTRIMERIC COILED COILS, KINK CONTAINING COILED- COILS, SIX HELIX-BUNDLE, TRANSPORT PROTEIN
4nrx:H (VAL2) to (GLY99) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE | IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM
4nrx:D (VAL2) to (GLY103) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE | IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM
4nry:H (VAL2) to (GLY99) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 | IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM
4nry:A (VAL2) to (GLY99) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 | IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM
4nrz:H (VAL2) to (ARG94) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6 | IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM
4nrz:A (VAL2) to (ALA93) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6 | IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM
4nrz:L (GLN3) to (TYR92) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6 | IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM
5c8j:A (GLN6) to (ARG101) A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE | MEMBRANE PROTEIN INSERTASE, MEMBRANE PROTEIN
5c8j:C (GLN6) to (SER105) A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE | MEMBRANE PROTEIN INSERTASE, MEMBRANE PROTEIN
5c8j:G (GLN6) to (ARG101) A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE | MEMBRANE PROTEIN INSERTASE, MEMBRANE PROTEIN
1l0x:A (ALA3) to (GLY97) TCR BETA CHAIN COMPLEXED WITH STREPTOCOCCAL SUPERANTIGEN SPEA | TCR, SUPERANTIGEN, IMMUNE SYSTEM
1l0x:C (ALA3) to (GLY97) TCR BETA CHAIN COMPLEXED WITH STREPTOCOCCAL SUPERANTIGEN SPEA | TCR, SUPERANTIGEN, IMMUNE SYSTEM
1l0y:A (ALA3) to (GLY97) T CELL RECEPTOR BETA CHAIN COMPLEXED WITH SUPERANTIGEN SPEA SOAKED WITH ZINC | TCR, SUPERANTIGEN, SPEA, IMMUNE SYSTEM
1l0y:C (ALA3) to (GLY97) T CELL RECEPTOR BETA CHAIN COMPLEXED WITH SUPERANTIGEN SPEA SOAKED WITH ZINC | TCR, SUPERANTIGEN, SPEA, IMMUNE SYSTEM
5cbe:A (GLN1) to (ASP100) E10 IN COMPLEX WITH CXCL13 | ANTI-CXCL13, E10, SCFV, IMMUNE SYSTEM
5cey:B (GLN3) to (TYR100) CRYSTAL STRUCTURE OF FAB 9H+3L, A PUTATIVE PRECURSOR OF THE PGT121 FAMILY OF POTENT HIV-1 ANTIBODIES | HIV-1, ANTIBODY, IMMUNE SYSTEM
2nx5:E (GLY3) to (THR96) CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A | TCR-PMHC, IMMUNE COMPLEX, IMMUNE SYSTEM
4ocx:H (VAL2) to (GLY100) FAB COMPLEX WITH METHOTREXATE | IGG1/K FAMILY, IMMUNE SYSTEM
1lmk:C (VAL2) to (ARG98) THE STRUCTURE OF A BIVALENT DIABODY | IMMUNOGLOBULIN, DIABODY, SINGLE-CHAIN FV, SCFV
1lp9:F (ALA2) to (ASP96) XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1 | IMMUNOREGULATORY COMPLEX, CLASS I MHC:TCR CO-CRYSTAL, IMMUNE SYSTEM
3k81:A (GLN3) to (ASN96) STRUCTURE OF THE CENTRAL INTERACTION PROTEIN FROM THE TRYPANOSOMA BRUCEI EDITOSOME IN COMPLEX WITH SINGLE DOMAIN ANTIBODIES | KREPA6, VHH, SINGLE DOMAIN ANTIBODY, IMMUNE SYSTEM, RNA BINDING PROTEIN
4olu:H (VAL2) to (TYR97) CRYSTAL STRUCTURE OF ANTIBODY VRC07 IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE | VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4om1:H (VAL2) to (TYR97) CRYSTAL STRUCTURE OF ANTIBODY VRC07-I30Q, G54W, S58N IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE | VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-I30Q, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5cws:B (GLN29) to (ALA123) CRYSTAL STRUCTURE OF THE INTACT CHAETOMIUM THERMOPHILUM NSP1-NUP49- NUP57 CHANNEL NUCLEOPORIN HETEROTRIMER BOUND TO ITS NIC96 NUCLEAR PORE COMPLEX ATTACHMENT SITE | NUCLEOCYTOPLASMIC TRANSPORT, PROTEIN TRANSPORT
5cws:H (GLN29) to (ALA123) CRYSTAL STRUCTURE OF THE INTACT CHAETOMIUM THERMOPHILUM NSP1-NUP49- NUP57 CHANNEL NUCLEOPORIN HETEROTRIMER BOUND TO ITS NIC96 NUCLEAR PORE COMPLEX ATTACHMENT SITE | NUCLEOCYTOPLASMIC TRANSPORT, PROTEIN TRANSPORT
1y0l:H (VAL2) to (ASP98) CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM
1y0l:D (VAL2) to (ASP98) CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM
1y0l:F (VAL2) to (ASP98) CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM
1mel:A (GLN3) to (THR101) CRYSTAL STRUCTURE OF A CAMEL SINGLE-DOMAIN VH ANTIBODY FRAGMENT IN COMPLEX WITH LYSOZYME | CAMEL SINGLE-DOMAIN ANTI-LYSOZYME, COMPLEX (ANTIBODY/ANTIGEN)
4ozf:G (MET2) to (GLY109) JR5.1 PROTEIN COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4ozi:G (LYS3) to (VAL106) S2 PROTEIN COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
5d1z:F (GLN1) to (ALA98) ISDB NEAT1 BOUND BY CLONE D4-10 | ISDB, NEAT1, GERMLINE ENCODED, IMMUNE SYSTEM
5d2n:C (LYS3) to (LEU90) CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX | TCR, NLV, HLA-A2, IMMUNE SYSTEM
5d7s:L (GLU3) to (SER86) CRYSTAL STRUCTURE OF MOR04357, A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT | GM-CSF, AFFINITY MATURATION, PHAGE DISPLAY, CYTOKINE, ANTIBODY, PROTEROS BIOSTRUCTURES GMBH, IMMUNE SYSTEM
5d9q:H (GLN1) to (TYR100) CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46 | HIV ENV GLYCOPROTEIN; BROADLY NEUTRALIZING ANTIBODIES; IMMUNE SYSTEM, IMMUNE SYSTEM
5d9q:F (GLN1) to (TYR100) CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46 | HIV ENV GLYCOPROTEIN; BROADLY NEUTRALIZING ANTIBODIES; IMMUNE SYSTEM, IMMUNE SYSTEM
5d9q:N (GLN1) to (TYR100) CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46 | HIV ENV GLYCOPROTEIN; BROADLY NEUTRALIZING ANTIBODIES; IMMUNE SYSTEM, IMMUNE SYSTEM
3l7f:H (VAL2) to (SER102) STRUCTURE OF IL-13 ANTIBODY H2L6, A HUMANIZED VARIANT OF C836 | IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3l7f:B (THR3) to (SER102) STRUCTURE OF IL-13 ANTIBODY H2L6, A HUMANIZED VARIANT OF C836 | IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5dmj:B (VAL2) to (LYS94) STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB | CELL SURFACE RECEPTOR, DOMAIN ANTIBODY, PROTEIN/PROTEIN INTERACTION, IMMUNE SYSTEM-SIGNALING PROTEIN COMPLEX
5dmj:E (VAL2) to (LYS94) STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB | CELL SURFACE RECEPTOR, DOMAIN ANTIBODY, PROTEIN/PROTEIN INTERACTION, IMMUNE SYSTEM-SIGNALING PROTEIN COMPLEX
5dmj:G (VAL2) to (LYS94) STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB | CELL SURFACE RECEPTOR, DOMAIN ANTIBODY, PROTEIN/PROTEIN INTERACTION, IMMUNE SYSTEM-SIGNALING PROTEIN COMPLEX
5dqj:A (VAL2) to (LEU98) STRUCTURE OF UNLIGANDED S55-5 FAB | ANTIBODY, FAB, CARBOHYDRATE BINDING, PHOSPHOLIPID, IMMUNE SYSTEM
1za6:D (VAL2) to (ARG98) THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY | IMMUNOGLOBULIN FOLD, CH2-DOMAIN-DELETION, IMMUNE SYSTEM
1zgl:T (VAL4) to (LEU96) CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A | TCR/PEPTIDE/MHC COMPLEX, IMMUNE SYSTEM
3lrs:C (GLU2) to (PRO99) STRUCTURE OF PG16, AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1 | NEUTRALIZING ANTIBODIES, LONG CDRH3, HIV-1, IMMUNE SYSTEM
5e5m:B (GLN5) to (THR100) CRYSTAL STRUCTURE OF MOUSE CTLA-4 IN COMPLEX WITH NANOBODY | THE COMPLEX OF MOUSE CTLA-4 WITH ITS NANOBODY, TREATMENT OF METASTATIC MELANOMAS, IMMUNE SYSTEM
5e5m:D (VAL4) to (THR100) CRYSTAL STRUCTURE OF MOUSE CTLA-4 IN COMPLEX WITH NANOBODY | THE COMPLEX OF MOUSE CTLA-4 WITH ITS NANOBODY, TREATMENT OF METASTATIC MELANOMAS, IMMUNE SYSTEM
5e5m:H (VAL4) to (LYS99) CRYSTAL STRUCTURE OF MOUSE CTLA-4 IN COMPLEX WITH NANOBODY | THE COMPLEX OF MOUSE CTLA-4 WITH ITS NANOBODY, TREATMENT OF METASTATIC MELANOMAS, IMMUNE SYSTEM
5e6i:L (VAL4) to (LEU95) CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2 | IMMUNE SYSTEM, TCR, HLA-A2, FLU, COMPLEX
5e94:B (ASP1) to (SER102) ANTIBODY-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN | ANTIBODY ANTAGONIST GLP-1 RECEPTOR, IMMUNE SYSTEM, MEMBRANE PROTEIN
2a6d:B (VAL2) to (TYR101) CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE RLLIADPPSPRE | GERMLINE, FAB, ANTIBODY, IMMUNE SYSTEM
2a6i:B (VAL2) to (TYR101) CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE KLASIPTHTSPL | IMMUNOGLOBULIN FOLD, FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM
4qhk:M (VAL2) to (PRO96) UCA (UNBOUND) FROM CH103 LINEAGE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
4qhk:K (VAL2) to (PRO96) UCA (UNBOUND) FROM CH103 LINEAGE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
2aab:H (GLN3) to (GLY99) STRUCTURAL BASIS OF ANTIGEN MIMICRY IN A CLINICALLY RELEVANT MELANOMA ANTIGEN SYSTEM | ANTI-IDIOTYPIC ANTIBODY, MOLECULAR MIMICRY, MELANOMA, IMMUNOTHERAPY, IMMUNE SYSTEM
2aeq:H (VAL2) to (TYR103) AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX. | INFLUENZA VIRUS NEURAMINIDASE-FAB COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX
3mlw:I (GLN3) to (ARG94) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3mlz:H (VAL2) to (GLY97) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A VI191 V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3mme:H (GLU2) to (ASP100) STRUCTURE AND FUNCTIONAL DISSECTION OF PG16, AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1 | NEUTRALIZING ANTIBODIES, LONG CDRH3, HIV-1, IMMUNE SYSTEM
3mme:A (GLU2) to (ASP100) STRUCTURE AND FUNCTIONAL DISSECTION OF PG16, AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1 | NEUTRALIZING ANTIBODIES, LONG CDRH3, HIV-1, IMMUNE SYSTEM
5erw:A (GLN1) to (ALA97) STRUCTURE OF HCV E2 GLYCOPROTEIN ANTIGENIC EPITOPE II BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC84-26 | IMMUNE SYSTEM, COMPLEX, HEPATITIS C VIRUS, E2 GLYCOPROTEIN, EPITOPE II, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4bh7:B (VAL2) to (TYR101) CRYSTAL STRUCTURE OF GERMLINE ANTIBODY 36-65 IN COMPLEX WITH PEPTIDE PPYPAWHAPGNI | IMMUNE SYSTEM, CONVERGENCE OF ANTIBODY SPECIFICITIES
5esv:C (GLN3) to (ARG94) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256. | HIV-1, ENV, V1V2, CH0219, CHAVI, SCAFFOLD, CAP256, IMMUNE SYSTEM
5esv:H (GLN3) to (THR96) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256. | HIV-1, ENV, V1V2, CH0219, CHAVI, SCAFFOLD, CAP256, IMMUNE SYSTEM
5esz:A (GLN3) to (ARG94) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244 | HIV-1, ENV, V1V2, CH0219, CHAVI, IMMUNE SYSTEM
5eu7:E (VAL2) to (SER101) CRYSTAL STRUCTURE OF HIV-1 INTEGRASE CATALYTIC CORE IN COMPLEX WITH FAB | INTEGRASE, FAB, HIV, VIRAL PROTEIN
5eu7:F (GLU1) to (SER101) CRYSTAL STRUCTURE OF HIV-1 INTEGRASE CATALYTIC CORE IN COMPLEX WITH FAB | INTEGRASE, FAB, HIV, VIRAL PROTEIN
3bik:C (TRP32) to (LEU128) CRYSTAL STRUCTURE OF THE PD-1/PD-L1 COMPLEX | CO-STIMULATION, RECEPTOR-LIGAND COMPLEX, IMMUNOGLOBULIN-LIKE BETA- SANDWICH, T CELL, B CELL, PROGRAMMED DEATH, IMMUNE SYSTEM, TRANSMEMBRANE, INHIBITORY RECEPTOR, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, APOPTOSIS
3bkc:H (VAL2) to (ARG94) CRYSTAL STRUCTURE OF ANTI-AMYLOID BETA FAB WO2 (P21, FORMB) | ABETA, AMYLOID BETA PEPTIDE, FAB, WO2, ALZHEIMER'S DISEASE, IMMUNOTHERAPIES, APP, IMMUNE SYSTEM
3bkm:H (VAL2) to (ARG94) STRUCTURE OF ANTI-AMYLOID-BETA FAB WO2 (FORM A, P212121) | ABETA, AMYLOID BETA PEPTIDE, FAB, WO2, ALZHEIMER'S DISEASE, IMMUNOTHERAPIES, APP, IMMUNE SYSTEM
5f6h:K (VAL2) to (ALA97) CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
5f6h:I (VAL2) to (TRP101) CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
5f6h:M (VAL2) to (TRP101) CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
5f6h:O (GLN3) to (ALA97) CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
5f6j:B (GLN3) to (ALA97) CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE IN COMPLEX WITH HIV-1 GP120 CORE | FAB FRAGMENT, HIV-1, ANTIBODY, VIRAL PROTEIN-IMMUE SYSTEM COMPLEX
5f6j:H (GLN3) to (LYS98) CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE IN COMPLEX WITH HIV-1 GP120 CORE | FAB FRAGMENT, HIV-1, ANTIBODY, VIRAL PROTEIN-IMMUE SYSTEM COMPLEX
5f96:H (VAL2) to (THR98) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235.12 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120 | HIV-1, ANTIBODY, CH235 LINEAGE, VH1-46 GERMLINE, IMMUNE SYSTEM
5f9o:H (VAL2) to (THR102) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235.09 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120 | ANTIBODY EVOLUTION HIV-1 BROADLY NEUTRALIZING CD4 BINDING SITE, IMMUNE SYSTEM
5f9w:B (VAL2) to (THR98) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120 | HIV-1, VH1-46 GERMLINE, NEUTRALIZING ANTIBODY, CH235, IMMUNE SYSTEM
5f9w:H (GLN3) to (THR98) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120 | HIV-1, VH1-46 GERMLINE, NEUTRALIZING ANTIBODY, CH235, IMMUNE SYSTEM
4r0l:H (GLN3) to (SER95) ANTI-CANINE CD28 ANTIBODY, 1C6, BOUND CANINE CD28 | IMMUNOGLOBULIN, T-CELL ACTIVATION, CD28, 1C6, IMMUNE SYSTEM
3c2a:H (GLN3) to (VAL100) ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE | ANTIBODY FAB HIV-1 PEPTIDE, ENVELOPE PROTEIN, IMMUNE SYSTEM
5feb:A (MET30) to (PRO132) CRYSTAL STRUCTURE OF THE VOLTAGE-GATED SODIUM CHANNEL BETA 2 SUBUNIT EXTRACELLULAR DOMAIN | MEMBRANE PROTEIN ION CHANNEL SODIUM, MEMBRANE PROTEIN
5fhc:L (ILE2) to (ASN90) CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP) | IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, EBOLA VIRUS, GLYCOPROTEIN, GP, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3cfk:H (VAL2) to (ASP98) CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION
3cfk:B (VAL2) to (ASP98) CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION
3cfk:F (VAL2) to (ASP98) CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION
3cfk:I (VAL2) to (ASP98) CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION
3cfk:P (VAL2) to (ASP98) CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION
3cfi:C (GLN3) to (ALA96) NANOBODY-AIDED STRUCTURE DETERMINATION OF THE EPSI:EPSJ PSEUDOPILIN HETERDIMER FROM VIBRIO VULNIFICUS | GENERAL SECRETORY PATHWAY, PSEUDOPILINS, SINGLE CHAIN ANTIBODY, METHYLATION, PROTEIN TRANSPORT-IMMUNE SYSTEM COMPLEX
3cfi:F (GLN3) to (ALA96) NANOBODY-AIDED STRUCTURE DETERMINATION OF THE EPSI:EPSJ PSEUDOPILIN HETERDIMER FROM VIBRIO VULNIFICUS | GENERAL SECRETORY PATHWAY, PSEUDOPILINS, SINGLE CHAIN ANTIBODY, METHYLATION, PROTEIN TRANSPORT-IMMUNE SYSTEM COMPLEX
3cfj:H (VAL2) to (ASP98) CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION
3cfj:D (VAL2) to (ASP98) CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION
4rfn:H (VAL2) to (TYR98) CRYSTAL STRUCTURE OF ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48 | HIV-1 GP120, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4rfn:B (GLN3) to (TYR98) CRYSTAL STRUCTURE OF ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48 | HIV-1 GP120, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ris:H (VAL2) to (ARG98) STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK | ANTIBODY, IGG FOLD, IMMUNE SYSTEM, HIV-1 GP120 V2 REGION
3ntc:H (VAL2) to (ILE96) CRYSTAL STRUCTURE OF KD-247 FAB, AN ANTI-V3 ANTIBODY THAT INHIBITS HIV-1 ENTRY | KD-247, HUMANIZED ANTIBODY, ANTI-V3, FAB, IMMUNE SYSTEM
4rnr:C (GLN3) to (VAL93) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV ANTIBODY PGT130 | PGT130, PGT 130, IMMUNOGLOBULIN FOLD, BROADLY NEUTRALIZING ANTIBODY, HIV-1 GP120 BINDING, N-LINKED GLYCAN, IMMUNE SYSTEM
5fv2:A (VAL2) to (CYS96) CRYSTAL STRUCTURE OF HVEGF IN COMPLEX WITH VH DOMAIN ANTIBODY | HORMONE, GROWTH FACTOR RECEPTOR, VEGF, DOMAIN ANTIBODY, VASCULAR ENDOTHELIAL GROWTH FACTOR
4rqq:H (GLN3) to (ARG100) CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY | IGG, ANTI-HIV-1 ANTIBODY, HIV-1 ENV TRIMER, IMMUNE SYSTEM
5fyj:E (LEU4) to (SER90) CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01 | VIRAL PROTEIN, HIV, ENVELOPE, GLYCAN, TRIMER
3d0l:B (ILE2) to (PRO98) CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671 | HIV, ANTIBODY, NEUTRALIZATION, EPITOPE, 2F5, GP41, IMMUNE SYSTEM
3oay:M (GLN3) to (GLY96) A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY | FAB, IMMUNE SYSTEM
3oay:H (GLN3) to (CYS92) A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY | FAB, IMMUNE SYSTEM
3det:C (VAL2) to (TYR103) STRUCTURE OF THE E148A, Y445A DOUBLY UNGATED MUTANT OF E.COLI CLC_EC1, CL-/H+ ANTIPORTER | CLC_EC1, ANTIPORTER, EXCHANGE-TRANSPORTER, DOUBLY UNGATED MUTANT, CHLORIDE, INNER MEMBRANE, ION TRANSPORT, MEMBRANE, STRESS RESPONSE, TRANSMEMBRANE, MEMBRANE PROTEIN
3det:E (VAL2) to (TYR103) STRUCTURE OF THE E148A, Y445A DOUBLY UNGATED MUTANT OF E.COLI CLC_EC1, CL-/H+ ANTIPORTER | CLC_EC1, ANTIPORTER, EXCHANGE-TRANSPORTER, DOUBLY UNGATED MUTANT, CHLORIDE, INNER MEMBRANE, ION TRANSPORT, MEMBRANE, STRESS RESPONSE, TRANSMEMBRANE, MEMBRANE PROTEIN
4tvp:H (GLN1) to (TYR100) CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN, COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41, IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 | HIV-1 ENVELOPE TRIMER, GP120, GP41, MEMBRANE FUSION, VIRAL ENTRY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, TYPE-1 MEMBRANE FUSION GLYCOPROTEIN
4tvs:a (GLN2) to (PHE101) LAP1(AA356-583), H.SAPIENS, BOUND TO VHH-BS1 | NUCLEAR ENVELOPE PROTEIN, AAA+-ASSOCIATED, ACTIVATOR, MEMBRANE PROTEIN
5gs2:H (GLN3) to (HIS101) CRYSTAL STRUCTURE OF DIABODY COMPLEX WITH REPEBODY AND MBP | DIABODY, ANTIBODY FRAGMENT, COMPLEX, SUGAR BINDING PROTEIN-IMMUNE SYSTEM COMPLEX
3dx9:B (GLY3) to (TYR108) CRYSTAL STRUCTURE OF THE DM1 TCR AT 2.75A | MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, IMMUNE SYSTEM
4dk3:A (GLN1) to (PHE101) STRUCTURE OF EDITOSOME PROTEIN | KREPA1, VHH, SINGLE DOMAIN ANTIBODY, PROTEIN BINDING, RNA BINDING PROTEIN-IMMUNE SYSTEM COMPLEX
4dk3:B (GLN1) to (ARG100) STRUCTURE OF EDITOSOME PROTEIN | KREPA1, VHH, SINGLE DOMAIN ANTIBODY, PROTEIN BINDING, RNA BINDING PROTEIN-IMMUNE SYSTEM COMPLEX
4dk6:A (GLN1) to (ARG100) STRUCTURE OF EDITOSOME PROTEIN | KREPA1, VHH, SINGLE DOMAIN ANTIBODY, PROTEIN BINDING, RNA BINDING PROTEIN-IMMUNE SYSTEM COMPLEX
4dk6:B (GLN1) to (ARG100) STRUCTURE OF EDITOSOME PROTEIN | KREPA1, VHH, SINGLE DOMAIN ANTIBODY, PROTEIN BINDING, RNA BINDING PROTEIN-IMMUNE SYSTEM COMPLEX
4dka:A (GLN1) to (PHE101) STRUCTURE OF EDITOSOME PROTEIN | KREPA1, VHH, SINGLE DOMAIN ANTIBODY, PROTEIN BINDING, RNA BINDING PROTEIN-IMMUNE SYSTEM COMPLEX
4dke:H (VAL2) to (GLY97) CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1 | DIMERIC FOUR-HELIX BUNDLE CYTOKINE, IGG, GLYCOSYLATION, CYTOKINE- IMMUNE SYSTEM COMPLEX
4udu:B (GLY4) to (LEU97) CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN E IN COMPLEX WITH A T CELL RECEPTOR | IMMUNE SYSTEM, SUPERANTIGEN, T CELL RECEPTOR, MAJOR HISTOCOMPATIBILITY COMPLEX
3pjs:D (GLN3) to (PRO100) MECHANISM OF ACTIVATION GATING IN THE FULL-LENGTH KCSA K+ CHANNEL | ION CHANNEL, CONDUCTS K+ IONS, CELL MEMBRANE, TRANSPORT PROTEIN
5i8h:I (GLN1) to (TYR100) CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB | HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM
5ibl:C (GLN3) to (ALA97) HUMAN ANTIBODY 6639 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 X-181 | HEMAGGLUTININ, COMPLEX, ANTIBODY, VACCINE, IMMUNE SYSTEM
5ibt:H (GLN3) to (ASP102) UCA FAB (UNBOUND) FROM 6515 LINEAGE | ANTIBODY, INFLUENZA, UNBOUND, IMMUNE SYSTEM
4uv4:H (GLN3) to (ASP100) CRYSTAL STRUCTURE OF ANTI-FPR FPRO0165 FAB FRAGMENT | IMMUNE SYSTEM, ANTIBODY ENGINEERING, PHAGE DISPLAY, LONG CDR, FORMYL PEPTIDE RECEPTOR-1
4edx:B (GLN3) to (TYR98) NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM MOUSE MAB 911 | CYSTINE KNOT, IMMUNOGLOBULIN, GROWTH/SURVIVAL FACTOR, IMMUNE SYSTEM
4edx:H (GLN3) to (TYR98) NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM MOUSE MAB 911 | CYSTINE KNOT, IMMUNOGLOBULIN, GROWTH/SURVIVAL FACTOR, IMMUNE SYSTEM
5ijv:B (VAL2) to (CYS105) CRYSTAL STRUCTURE OF BOVINE FAB E03 | ANTIBODY FAB ULTRALONG CDR H3, IMMUNE SYSTEM
5ijv:F (GLN3) to (THR93) CRYSTAL STRUCTURE OF BOVINE FAB E03 | ANTIBODY FAB ULTRALONG CDR H3, IMMUNE SYSTEM
4ene:C (VAL2) to (TYR103) STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX | MEMBRANE PROTEIN, COUPLED ION TRANSPORTER, CELL MEMBRANE, TRANSPORT PROTEIN
4ene:E (VAL2) to (TYR103) STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX | MEMBRANE PROTEIN, COUPLED ION TRANSPORTER, CELL MEMBRANE, TRANSPORT PROTEIN
3q6f:F (VAL2) to (LYS94) CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120 | IGG, NEUTRALIZATION OF HIV-1 VIRUSES, QUATERNARY EPITOPE OF HIV-1 GP120, IMMUNE SYSTEM
3q6f:J (VAL2) to (LYS94) CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120 | IGG, NEUTRALIZATION OF HIV-1 VIRUSES, QUATERNARY EPITOPE OF HIV-1 GP120, IMMUNE SYSTEM
5ivo:A (GLN3) to (ALA97) BC2 NANOBODY | NANOBODY, TAG, CAPTURE, AFFINITY, CATENIN, PEPTIDE BINDING PROTEIN
5iwl:B (VAL2) to (ARG98) CD47-DIABODY COMPLEX | RECEPTOR, DIABODY, COMPLEX, CELL ADHESION
5iwl:A (VAL2) to (ARG98) CD47-DIABODY COMPLEX | RECEPTOR, DIABODY, COMPLEX, CELL ADHESION
3qhz:H (LEU4) to (LEU96) CRYSTAL STRUCTURE OF HUMAN ANTI-INFLUENZA FAB 2D1 | IMMUNOGLOBULIN, IMMUNE RECOGNITION, INFLUENZA A HEMAGGLUTININ, IMMUNE SYSTEM
4f9l:D (VAL3) to (HIS92) CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 20.1 SINGLE CHAIN ANTIBODY | B7 SUPERFAMILY, BUTYROPHILIN, CD277, IMMUNE SYSTEM
3qny:B (GLN3) to (ILE100) MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3qxv:A (VAL4) to (ASP102) STRUCTURE OF AN ANTI-METHOTREXATE CDR1-4 GRAFT VHH ANTIBODY IN COMPLEX WITH METHOTREXATE | CAMELID SINGLE DOMAIN ANTIBODY, HEAVY CHAIN ONLY, VHH, ANTIBODY, ANTI-HAPTEN ANTIBODY, CDR,HAPTEN BINDING, SMALL MOLECULE SENSING, LIGAND BINDING, LOW MOLECULAR WEIGHT COMPOUND, METHOTREXATE, IMMUNE SYSTEM
3qxv:C (GLN5) to (ASP102) STRUCTURE OF AN ANTI-METHOTREXATE CDR1-4 GRAFT VHH ANTIBODY IN COMPLEX WITH METHOTREXATE | CAMELID SINGLE DOMAIN ANTIBODY, HEAVY CHAIN ONLY, VHH, ANTIBODY, ANTI-HAPTEN ANTIBODY, CDR,HAPTEN BINDING, SMALL MOLECULE SENSING, LIGAND BINDING, LOW MOLECULAR WEIGHT COMPOUND, METHOTREXATE, IMMUNE SYSTEM
4w6y:B (GLN1) to (GLU101) CO-COMPLEX STRUCTURE OF THE LECTIN DOMAIN OF F18 FIMBRIAL ADHESIN FEDF WITH INHIBITORY NANOBODY NBFEDF9 | ADHESIN, FIMBRIAE, CELL ADHESION, INHIBITOR
3r0m:B (GLN3) to (PRO98) CRYSTAL STRUCTURE OF ANTI-HIV LLAMA VHH ANTIBODY A12 | IG DOMAIN, IMMUNE SYSTEM
4fqj:H (VAL2) to (ARG94) INFLUENZA B/FLORIDA/4/2006 HEMAGGLUTININ FAB CR8071 COMPLEX | MONOCLONAL, IMMUNOGLOBULIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqk:E (VAL2) to (ARG94) INFLUENZA B/BRISBANE/60/2008 HEMAGGLUTININ FAB CR8059 COMPLEX | ANTIBODY, FAB FRAGMENT, MONOCLONAL, IMMUNOGLOBULIN, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
4fqk:H (VAL2) to (ARG94) INFLUENZA B/BRISBANE/60/2008 HEMAGGLUTININ FAB CR8059 COMPLEX | ANTIBODY, FAB FRAGMENT, MONOCLONAL, IMMUNOGLOBULIN, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
3rgv:A (ASP1) to (SER93) A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS | TCR, MHC, MHC CLASS I, IMMUNE SYSTEM
5jo5:H (VAL2) to (TYR98) CRYSTAL STRUCTURE OF 10E8 GHV-GLV ANTIGEN-BINDING FRAGMENT. | MPER, HIV-1, ANTIBODY DEVELOPMENT, NEUTRALIZING, IMMUNE SYSTEM
5jo5:A (VAL2) to (LYS97) CRYSTAL STRUCTURE OF 10E8 GHV-GLV ANTIGEN-BINDING FRAGMENT. | MPER, HIV-1, ANTIBODY DEVELOPMENT, NEUTRALIZING, IMMUNE SYSTEM
5jo5:E (VAL2) to (TYR98) CRYSTAL STRUCTURE OF 10E8 GHV-GLV ANTIGEN-BINDING FRAGMENT. | MPER, HIV-1, ANTIBODY DEVELOPMENT, NEUTRALIZING, IMMUNE SYSTEM
4g6a:H (LEU4) to (THR97) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
5k9q:H (VAL2) to (ARG98) CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ | HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
5k9q:J (VAL2) to (ARG98) CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ | HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
5k9q:S (VAL2) to (ARG98) CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ | HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
5k9q:U (VAL2) to (ARG98) CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ | HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
5k9q:X (VAL2) to (ARG98) CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ | HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
5kan:H (VAL2) to (ARG98) CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ | INFLUENZA, MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
5sv3:C (VAL2) to (ALA97) RTA1-33/44-198 (RVEC) BOUND TO SINGLE DOMAIN ANTIBODY A3C8 | RICIN, A-CHAIN, RVEC, SDAB, ANTIBODY, RTA1-33/44-198, TOXIN
5t33:H (GLN1) to (ASN94) CRYSTAL STRUCTURE OF STRAIN-SPECIFIC GLYCAN-DEPENDENT CD4 BINDING SITE-DIRECTED NEUTRALIZING ANTIBODY CAP257-RH1, IN COMPLEX WITH HIV-1 STRAIN RHPA GP120 CORE WITH AN OLIGOMANNOSE N276 GLYCAN. | HIV, STRAIN-SPECIFIC, NEUTRALIZING ANTIBODY, CD4 BINDING SITE, N276 GLYCAN, GLYCAN-FREE V5, IMMUNE SYSTEM
5t3z:H (GLN3) to (TYR100) 3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074 | HIV, N-LINKED GLYCOSYLATION, BROADLY NEUTRALIZING ANTIBODIES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1nc2:A (GLN1) to (SER95) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y- DOTA | ANTIBODY-DOTA COMPLEX, RARE EARTH, DOTA, METAL CHELATE, YTTRIUM, GAMMA TURN, N-LINKED GLYCOSYLATION, IMMUNE SYSTEM
1nc2:C (GLN1) to (SER95) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y- DOTA | ANTIBODY-DOTA COMPLEX, RARE EARTH, DOTA, METAL CHELATE, YTTRIUM, GAMMA TURN, N-LINKED GLYCOSYLATION, IMMUNE SYSTEM
1nca:H (ILE2) to (ARG94) REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX | HYDROLASE(O-GLYCOSYL)
2aq1:C (ALA3) to (SER94) CRYSTAL STRUCTURE OF T-CELL RECEPTOR V BETA DOMAIN VARIANT COMPLEXED WITH SUPERANTIGEN SEC3 MUTANT | T-CELL RECEPTOR, STAPHYLOCOCCAL ENTEROTOXIN C3, SUPERANTIGEN, COMPLEX (TOXIN/RECEPTOR), IMMUNE SYSTEM
4xvs:H (VAL2) to (GLY99) CRYSTAL STRUCTURE OF HIV-1 DONOR 45 D45-01DG5 COREE GP120 WITH ANTIBODY 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) | HIV-1 ANTIBODYOMICS NEUTRALIZING ANTIBODY GERMLINE BINDING, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4xx1:O (TYR2) to (SER92) LOW RESOLUTION STRUCTURE OF LCAT IN COMPLEX WITH FAB1 | A/B HYDROLASE, COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX
1qnz:H (GLN113) to (HIS211) NMR STRUCTURE OF THE 0.5B ANTI-HIV ANTIBODY COMPLEX WITH THE GP120 V3 PEPTIDE | ANTIBODY, V3 PEPTIDE, BINDING SITE, IMMUNE SYSTEM
4jrx:E (GLY3) to (GLU109) CRYSTAL STRUCTURE OF CA5 TCR-HLA B*3505-LPEP COMPLEX | TCR, T CELL, HLA B*3508, LPEP, EBV, ALLOREACTIVITY, IMMUNE SYSTEM
4yzf:G (VAL2) to (TYR102) CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3 | IMMUNE SYSTEM, HUMAN MEMBRANE PROTEIN, ANION EXCHANGER, ERYTHROCYTES
4yzf:I (VAL2) to (TYR102) CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3 | IMMUNE SYSTEM, HUMAN MEMBRANE PROTEIN, ANION EXCHANGER, ERYTHROCYTES
4yzf:K (VAL2) to (TYR102) CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3 | IMMUNE SYSTEM, HUMAN MEMBRANE PROTEIN, ANION EXCHANGER, ERYTHROCYTES
4kjp:C (VAL2) to (TYR103) STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE | MEMBRANE TRANSPORTING PROTEIN, TRANPORT PROTEIN, MEMBRANE PROTEIN
4kjp:E (VAL2) to (TYR103) STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE | MEMBRANE TRANSPORTING PROTEIN, TRANPORT PROTEIN, MEMBRANE PROTEIN
2vir:B (GLN3) to (ARG97) INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY | COMPLEX (HEMAGGLUTININ/IMMMUNOGLOBULIN), GLYCOPROTEIN
4kk8:C (VAL2) to (TYR103) STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN
4kk8:E (VAL2) to (TYR103) STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN
4zg1:A (GLN1) to (ASN96) CRYSTAL STRUCTURE OF A NANOBODY RAISED AGAINST KDM5B | NANOBODY, SINGLE DOMAIN ANTIBODY, CDR3 LOOP, BETA SANDWICH, PROTEIN BINDING
4zg1:B (GLN1) to (ASN96) CRYSTAL STRUCTURE OF A NANOBODY RAISED AGAINST KDM5B | NANOBODY, SINGLE DOMAIN ANTIBODY, CDR3 LOOP, BETA SANDWICH, PROTEIN BINDING
4zg1:D (GLN1) to (ASN96) CRYSTAL STRUCTURE OF A NANOBODY RAISED AGAINST KDM5B | NANOBODY, SINGLE DOMAIN ANTIBODY, CDR3 LOOP, BETA SANDWICH, PROTEIN BINDING
4zg1:E (GLN1) to (ASN96) CRYSTAL STRUCTURE OF A NANOBODY RAISED AGAINST KDM5B | NANOBODY, SINGLE DOMAIN ANTIBODY, CDR3 LOOP, BETA SANDWICH, PROTEIN BINDING
4zg1:F (GLN1) to (ASN96) CRYSTAL STRUCTURE OF A NANOBODY RAISED AGAINST KDM5B | NANOBODY, SINGLE DOMAIN ANTIBODY, CDR3 LOOP, BETA SANDWICH, PROTEIN BINDING
3i9g:H (VAL2) to (PHE97) CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE | ANTIBODY, FAB, SPHINGOSINE-1-PHOSPHATE, CALCIUM, IMMUNOGLOBIN, IGG, IMMUNE SYSTEM
1h5b:A (GLN3) to (GLU91) T CELL RECEPTOR VALPHA11 (AV11S5) DOMAIN | T CELL RECEPTOR, IMMUNE RESPONSE, IMMUNOGLOBULIN FOLD
2h2s:C (ARG3) to (TYR103) CRYSTAL STRUCTURE OF E148A MUTANT OF CLC-EC1 IN SECN- | CLC; TRANSPORTER; CHLORIDE; ANTIPORT, ION TRANSPORT
1it9:H (GLN3) to (TYR102) CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT FROM A HUMANIZED VERSION OF THE ANTI-HUMAN FAS ANTIBODY HFE7A | IMMUNOGLOBULIN, FAB, ANTI_FAS, AGONISTIC_ANTIBODY, APOPTOSIS, ANTIBODY_HUMANIZATION, IMMUNE SYSTEM
1kxv:D (GLN3) to (TYR101) CAMELID VHH DOMAINS IN COMPLEX WITH PORCINE PANCREATIC ALPHA-AMYLASE | BETA 8 ALPHA 8, BETA BARREL, HYDROLASE, IMMUNE SYSTEM
4oly:H (VAL2) to (LYS96) CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54R IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE | VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54R, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1y18:H (VAL2) to (ASP98) FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM
1y18:D (VAL2) to (ASP98) FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM
1y18:F (VAL2) to (ASP98) FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM
1n0x:K (VAL2) to (ARG94) CRYSTAL STRUCTURE OF A BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY IN COMPLEX WITH A PEPTIDE MIMOTOPE | ANTIBODY-PEPTIDE COMPLEX, PEPTIDE DIMER, IMMUNE SYSTEM
5dd6:A (GLN1) to (PRO99) CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES | HIV HIV-1 GP41 MPER ANTIBODY, IMMUNE SYSTEM
3ln9:A (GLN3) to (ALA98) CRYSTAL STRUCTURE OF THE FIBRIL-SPECIFIC B10 ANTIBODY FRAGMENT | COMPLEMENTARITY DETERMINING REGIONS, CDR, CAMELIDS, IMMUNOGLOBULIN HEAVY CHAINS, FIBRIL-SPECIFIC, FIBRIL RECOGNITION, ALZHEIMER'S DISEASE, AMYLOID, IMMUNE SYSTEM
2a6k:B (VAL2) to (ARG98) CRYSTAL STRUCTURE ANALYSIS OF THE GERMLINE ANTIBODY 36-65 FAB IN COMPLEX WITH THE DODECAPEPTIDE SLGDNLTNHNLR | IMMUNOGLOBULIN FOLD, FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM
5f3b:A (VAL2) to (ARG98) STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY | MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
5f3b:E (VAL2) to (ARG98) STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY | MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
3byt:C (ALA3) to (SER94) A COMPLEX BETWEEN A VARIANT OF STAPHYLOCOCCAL ENTEROTOXIN C3 AND THE VARIABLE DOMAIN OF THE MURINE T CELL RECEPTOR BETA CHAIN 8.2 | SECRETED, SUPERANTIGEN, TOXIN
4r2g:Q (LEU4) to (TYR100) CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4 | PROTEIN-PROTEIN COMPLEX, IGG, ANTI-HIV ANTIBODIES, GP120, IMMUNE SYSTEM
4r2g:D (LEU4) to (TYR100) CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4 | PROTEIN-PROTEIN COMPLEX, IGG, ANTI-HIV ANTIBODIES, GP120, IMMUNE SYSTEM
3c6l:E (VAL3) to (ASP93) CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR 2W20 | TCR-PMHC COMPLEX, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC II, TRANSMEMBRANE, SUGAR BINDING PROTEIN/IMMUNE SYSTEM COMPLEX
4rgn:L (VAL3) to (HIS92) STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES, 14G8 AND 6D3 | NEUTRALIZING ANTIBODY, STAPHYLOCOCCAL ENTEROTOXIN B, TOXIN-IMMUNE SYSTEM COMPLEX
4u0r:B (VAL2) to (TYR103) PLASMODIUM FALCIPARUM RETICULOCYTE-BINDING PROTEIN HOMOLOGUE 5 (PFRH5) BOUND TO MONOCLONAL ANTIBODY 9AD4 | MALARIA ERYTHROCYTE INVASION ANTIBODY-MEDIATED INHIBITION, IMMUNE SYSTEM
5hvg:D (GLN3) to (HIS96) CRYSTAL STRUCTURE OF THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR IN COMPLEX WITH AN INHIBITORY NANOBODY (VHH-A204) | PROCARBOXYPEPTIDASE U, THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR, TAFI, PROCARBOXYPEPTIDASE R, PLASMA PROCARBOXYPEPTIDASE B, NANOBODY, ANTIBODY FRAGMENT, PROTEIN COMPLEX, HYDROLASE/HYDROLASE INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5hys:H (GLU1) to (TYR102) STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB | IMMUNE SYSTEM
5hys:E (GLU1) to (HIS101) STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB | IMMUNE SYSTEM
3piq:G (VAL2) to (ASP100) CRYSTAL STRUCTURE OF HUMAN 2909 FAB, A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1 | MONOCLONAL ANTIBODY, NEUTRALIZING, HIV-1, QUATERNARY EPITOPE, TRIMERIC ENVELOPE SPIKE, IMMUNE SYSTEM
3piq:J (VAL2) to (ASP100) CRYSTAL STRUCTURE OF HUMAN 2909 FAB, A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1 | MONOCLONAL ANTIBODY, NEUTRALIZING, HIV-1, QUATERNARY EPITOPE, TRIMERIC ENVELOPE SPIKE, IMMUNE SYSTEM
5iq9:A (VAL2) to (ASP100) CRYSTAL STRUCTURE OF 10E8V4 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE. | IMMUNOGLOBULIN, MPER, ANTIBODY, IMMUNE SYSTEM
3qq9:L (ILE2) to (ILE96) CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F | IMMUNE SYSTEM, RSV F PROTEIN
3qxw:C (VAL4) to (ASP102) FREE STRUCTURE OF AN ANTI-METHOTREXATE CDR1-4 GRAFT VHH ANTIBODY | CAMELID SINGLE DOMAIN ANTIBODY, HEAVY CHAIN ONLY, VHH, ANTIBODY, ANTI-HAPTEN ANTIBODY, CDR, HAPTEN BINDING, SMALL MOLECULE SENSING, LIGAND BINDING, LOW MOLECULAR WEIGHT COMPOUND, METHOTREXATE, IMMUNE SYSTEM
3qxw:D (GLN5) to (ASP102) FREE STRUCTURE OF AN ANTI-METHOTREXATE CDR1-4 GRAFT VHH ANTIBODY | CAMELID SINGLE DOMAIN ANTIBODY, HEAVY CHAIN ONLY, VHH, ANTIBODY, ANTI-HAPTEN ANTIBODY, CDR, HAPTEN BINDING, SMALL MOLECULE SENSING, LIGAND BINDING, LOW MOLECULAR WEIGHT COMPOUND, METHOTREXATE, IMMUNE SYSTEM
3qxw:E (GLN3) to (ASP102) FREE STRUCTURE OF AN ANTI-METHOTREXATE CDR1-4 GRAFT VHH ANTIBODY | CAMELID SINGLE DOMAIN ANTIBODY, HEAVY CHAIN ONLY, VHH, ANTIBODY, ANTI-HAPTEN ANTIBODY, CDR, HAPTEN BINDING, SMALL MOLECULE SENSING, LIGAND BINDING, LOW MOLECULAR WEIGHT COMPOUND, METHOTREXATE, IMMUNE SYSTEM
4fqq:B (GLN3) to (TYR100) CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB | IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM
4g6f:B (VAL2) to (ASP100) CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE | IMMUNOGLOBULIN, MPER, ANTIBODY, IMMUNE SYSTEM
4g80:A (VAL2) to (GLN100) CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT, 3.8 A) | MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE
4g80:C (VAL2) to (GLN100) CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT, 3.8 A) | MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE
4g80:E (VAL2) to (GLN100) CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT, 3.8 A) | MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE
4g80:G (VAL2) to (GLN100) CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT, 3.8 A) | MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE